User: Guest  Login
Title:

Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.

Document type:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Article
Author(s):
Kastrati, A; Mehilli, J; Schlotterbeck, K; Dotzer, F; Dirschinger, J; Schmitt, C; Nekolla, SG; Seyfarth, M; Martinoff, S; Markwardt, C; Clermont, G; Gerbig, HW; Leiss, J; Schwaiger, M; Schömig, A
Abstract:
CONTEXT: The optimal pharmacological strategy for bridging the delay between admission and performance of percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (MI) is not known. OBJECTIVE: To assess whether early administration of reteplase plus abciximab produces better results compared with abciximab alone in patients with acute MI referred for PCI. DESIGN, SETTING, AND PATIENTS: Open-label, randomized controlled study conducted from May 3, 2001, through June 2...     »
Journal title abbreviation:
JAMA
Year:
2004
Journal volume:
291
Journal issue:
8
Pages contribution:
947-54
Language:
eng
Fulltext / DOI:
doi:10.1001/jama.291.8.947
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/14982910
Print-ISSN:
0098-7484
TUM Institution:
I. Medizinische Klinik und Poliklinik (Kardiologie); Institut für Radiologie; Klinik und Poliklinik für Nuklearmedizin
 BibTeX